Semi-Annual Statement Of Cash Flows

K Pharma,Inc. - Filing #7344418

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2021-12-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
301,076,000 JPY
-390,526,000 JPY
Impairment losses
43,107,000 JPY
31,293,000 JPY
Interest and dividend income
-16,000 JPY
-7,000 JPY
Decrease (increase) in inventories
-598,000 JPY
-313,000 JPY
Increase (decrease) in trade payables
1,750,000 JPY
7,468,000 JPY
Other, net
92,000 JPY
90,000 JPY
Subtotal
456,310,000 JPY
-362,909,000 JPY
Interest and dividends received
16,000 JPY
7,000 JPY
Income taxes paid
-1,901,000 JPY
-580,000 JPY
Net cash provided by (used in) operating activities
454,425,000 JPY
-363,482,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-9,803,000 JPY
-29,958,000 JPY
Other, net
JPY
-220,000 JPY
Net cash provided by (used in) investing activities
-11,099,000 JPY
-32,737,000 JPY
Cash flows from financing activities
Proceeds from issuance of shares
1,496,325,000 JPY
1,544,375,000 JPY
Net cash provided by (used in) financing activities
1,486,235,000 JPY
1,544,285,000 JPY
Other, net
-90,000 JPY
-90,000 JPY
Net increase (decrease) in cash and cash equivalents
1,929,560,000 JPY
1,148,065,000 JPY
Cash and cash equivalents
3,266,408,000 JPY
1,336,847,000 JPY
188,782,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.